The Potential Role of the Pharmacist in Supporting Patients with Depression - A Literature-Based Point of View.

depression drug-related problems guideline pharmaceutical care pharmacists

Journal

Integrated pharmacy research & practice
ISSN: 2230-5254
Titre abrégé: Integr Pharm Res Pract
Pays: New Zealand
ID NLM: 101656778

Informations de publication

Date de publication:
2020
Historique:
received: 25 11 2019
accepted: 24 01 2020
entrez: 13 3 2020
pubmed: 13 3 2020
medline: 13 3 2020
Statut: epublish

Résumé

The current article is aimed at identifying the best practice for counseling around depression in community and outpatient pharmacies, resulting in a draft guideline, proposing key steps and an algorithm for integration of community pharmacists into care for patients with depression. A literature review was performed followed by a detailed analysis, for the purpose of creation a short draft document used as a basis for creation of a guideline for pharmaceutical care for patients with depression. The technological scheme PRISMA flow diagram was applied. The paper is based on current knowledge, taking into consideration already published articles, guidelines, and recommendations about pharmaceutical care for patients with depression, giving a basis for further studies. This paper includes two main sections: 1) depression - a short description of the main symptoms, risk factors and pharmacotherapy guidelines available in Bulgaria important for the purposes of ensuring qualitative community-based pharmaceutical care; and 2) the pharmacists' role in providing high-quality care - the main aspects of pharmaceutical care for patients with depression with specific examples. The involvement of pharmacists in supporting depressive patients is crucial taking into account the specific characteristics of the pharmacological treatment: delayed onset of clinical results, risks in case of sudden pharmacotherapy abruption without physician consultation, multiple adverse drug reactions and drug-drug, drug-food and drug-alcohol interactions, etc. The current article could also be used as an initial document for creating a methodological guideline for providing pharmaceutical care services for patients with depression.

Identifiants

pubmed: 32161716
doi: 10.2147/IPRP.S239672
pii: 239672
pmc: PMC7049755
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

49-63

Informations de copyright

© 2020 Kamusheva et al.

Déclaration de conflit d'intérêts

All authors declare that they have no competing interests.

Références

Expert Opin Pharmacother. 2005 Mar;6(3):369-76
pubmed: 15794728
PLoS One. 2013 Aug 12;8(8):e70588
pubmed: 23950967
PLoS One. 2014 Apr 02;9(4):e91936
pubmed: 24694747
Springerplus. 2015 Sep 02;4:470
pubmed: 26357601
BMC Psychiatry. 2015 Sep 16;15:219
pubmed: 26376830
Prev Chronic Dis. 2016 Oct 27;13:E149
pubmed: 27788064
Curr Immunol Rev. 2010 Aug;6(3):205-212
pubmed: 21170282
J Clin Psychiatry. 2011 Aug;72(8):1054-62
pubmed: 20584525
Int J Environ Res Public Health. 2014 Oct 21;11(10):10967-90
pubmed: 25337943
Indian J Psychol Med. 2010 Jan;32(1):1-2
pubmed: 21799550
P T. 2015 Jan;40(1):36-40
pubmed: 25628505
Ment Health Clin. 2018 Mar 23;7(3):101-105
pubmed: 29955506
Ther Adv Psychopharmacol. 2011 Jun;1(3):81-7
pubmed: 23983930
J Ment Health. 2016 Dec;25(6):550-559
pubmed: 26607639
Int J Soc Psychiatry. 2018 Feb;64(1):37-48
pubmed: 29219031
J Manag Care Spec Pharm. 2017 Jan;23(1):74-84
pubmed: 28025928
Yakugaku Zasshi. 2019;139(4):539-543
pubmed: 30930384
WMJ. 2013 Jun;112(3):124-8
pubmed: 23894810
Psychiatr Clin North Am. 2012 Mar;35(1):1-14
pubmed: 22370487
Patient Prefer Adherence. 2012;6:87-100
pubmed: 22346345
Ann Gen Psychiatry. 2017 Mar 6;16:17
pubmed: 28286537
Syst Rev. 2018 May 2;7(1):71
pubmed: 29720247
Med Care Res Rev. 2013 Jun;70(3):235-66
pubmed: 23035056
Am J Hosp Pharm. 1990 Mar;47(3):533-43
pubmed: 2316538
EMBO Rep. 2016 Sep;17(9):1245-9
pubmed: 27491723
Acta Med Port. 2005 Nov-Dec;18(6):459-65
pubmed: 16684486
Rev Calid Asist. 2012 Jan-Feb;27(1):55-64
pubmed: 21982751
Br J Clin Pharmacol. 2017 Jan;83(1):192-201
pubmed: 27510273
Am J Pharm Educ. 2014 Mar 12;78(2):43
pubmed: 24672076
Can Pharm J (Ott). 2018 Feb 09;151(2):142-148
pubmed: 29531632

Auteurs

Maria Kamusheva (M)

Department of "Organization and Economics of Pharmacy", Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.

Desislava Ignatova (D)

Department of "Psychiatry and Clinical Psychology", Faculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.

Anna Golda (A)

Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University MC, Krakow, Poland.

Agnieszka Skowron (A)

Department of Social Pharmacy, Faculty of Pharmacy, Jagiellonian University MC, Krakow, Poland.

Classifications MeSH